Alzheimer's Disease‐Related Analytes Amyloid‐β and Tau in Perilymph: Correlation With Patient Age and Cognitive Score
Otolaryngology–Head and Neck Surgery · 2024
DOI: 10.1002/ohn.942 ↗At a glance
Journal article in Otolaryngology–Head and Neck Surgery, 2024. Written by Amit Walia and 10 co-authors. Institution: Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine in St Louis, St Louis, Missouri, USA. Major MEDLINE topics: Amyloid beta-Peptides, tau Proteins, Alzheimer Disease, Perilymph. Cited 1 times so far (Crossref); 57 references. The full text is freely available in PubMed Central. Funded by: NIDCD NIH HHS.
Topics: Demenz
Abstract (original language)
Objective
To describe the collection methods for perilymph fluid biopsy during cochlear implantation, detect levels of amyloid β 42 and 40 (Aβ 42 and Aβ 40 ), and total tau (tTau) analytes with a high‐precision assay, to compare these levels with patient age and Montreal Cognitive Assessment (MoCA) scores, and explore potential mechanisms and relationships with otic pathology. Study Design Prospective study.
Setting
Tertiary referral center.
Methods
Perilymph was collected from 25 patients using polyimide tubing to avoid amyloid adherence to glass, and analyzed with a single‐molecule array advanced digital enzyme‐linked immunosorbent assay platform for Aβ 40 , Aβ 42 , and tTau. Cognition was assessed by MoCA.
Results
Perilymph volumes ranged from ∼1 to 13 µL, with analyte concentrations spanning 2.67 to 1088.26 pg/mL. All samples had detectable levels of tTau, Aβ 40 , and Aβ 42 , with a significant positive correlation between Aβ 42 and Aβ 40 levels. Levels of Aβ 42 , Aβ 40 , and tTau were positively correlated with age, while MoCA scores were inversely correlated with age. tTau and Aβ 42 /Aβ 40 ‐ratios were significantly correlated with MoCA scores.
Conclusion
Alzheimer's disease‐associated peptides Aβ 42 , Aβ 40 , and tau analytes are detectable in human perilymph at levels approximately 10‐fold lower than those found in cerebrospinal fluid (CSF). These species increase with age and correlate with cognitive impairment indicators, suggesting their potential utility as biomarkers for cognitive impairment in patients undergoing cochlear implantation. Future research should investigate the origin of these analytes in the perilymph and their potential links to inner ear pathologies and hearing loss, as well as their relationships to CSF and plasma levels in individuals.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine in St Louis, St Louis, Missouri, USA.
- Department of Neurology, Washington University School of Medicine in St Louis, St Louis, Missouri, USA.
- Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University in St. Louis, St. Louis, Missouri, USA.
ORCID profiles: Amit Walia
Funding
- NIDCD NIH HHS
Cite
APA
Walia, A., Shew, M. A., Durakovic, N., Herzog, J. A., Cirrito, J. R., Yuede, C. M., Wick, C. C., Manis, M., Holtzman, D. M., Buchman, C. A., & Rutherford, M. A. (2024). Alzheimer's Disease‐Related Analytes Amyloid‐β and Tau in Perilymph: Correlation With Patient Age and Cognitive Score. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.942
Vancouver
Walia A, Shew MA, Durakovic N, Herzog JA, Cirrito JR, Yuede CM, et al. Alzheimer's Disease‐Related Analytes Amyloid‐β and Tau in Perilymph: Correlation With Patient Age and Cognitive Score. Otolaryngology–Head and Neck Surgery. 2024. doi:10.1002/ohn.942
BibTeX
@article{Walia2024,
author = {Walia, Amit and Shew, Matthew A and Durakovic, Nedim and Herzog, Jacques A and Cirrito, John R and Yuede, Carla M and Wick, Cameron C and Manis, Melissa and Holtzman, David M and Buchman, Craig A and Rutherford, Mark A},
title = {Alzheimer's Disease‐Related Analytes Amyloid‐β and Tau in Perilymph: Correlation With Patient Age and Cognitive Score},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2024},
doi = {10.1002/ohn.942}
}
EUVIMED